Salvona doesn't just make active ingredients, we make them work better.

​Salvona's technologies are used across the globe to solve problems in formulations for topical applications. Our technology helps actives in these applications to work better and give consumers their full benefits. Watch the video below to learn a little more!

 

Founded to benefit consumers AND the environment

Salvona Technologies was founded in 1999 by MIT and Harvard scientists Sam Shefer and Dr. Adi Shefer, who established a proprietary platform for drug delivery systems.

Salvona has followed its founding principles of offering exclusive, proprietary technologies that are eco-friendly and based on natural materials that are safe for both consumers and the environment. The company operates its cGMP facility that produces Rx, OTC and cosmetic products — all under the same restrictive guidelines and FDA inspections. This ensures that Salvona products are effective and safe to use.

A world-class, high-tech company, all under one roof.

Our full-service 30,000 sq. ft. facility in Hamilton, NJ is a modern example of an agile research, development, and manufacturing firm. Our building is home to all phases of the production of cosmetic, hair care, skin care, and pharmaceutical products. Salvona can do it all for you.

We're ready to provide your company with:

  • Developing marketing concepts & materials
  • Formulation compatibility testing
  • Microbial challenge testing
  • Packaging sourcing
  • Pre-clinical studies
  • Product consumer research
  • Small batch "proof of concept" samples
    Regulatory management
  • Safety testing
  • Stability and accelerated aging
  • Turn-key, finished, products

We have all of the right tools to
make a difference in your product.

Our clients expect to work with a partner that has the right lab equipment available to quickly and effectively perform testing. At Salvona, you will find top-of-the-line tools that cut significant R&D costs, while still maintainingthe highest quality product.

 


Dissolution


Fourier Transform Infrared Spectroscopy (FTIR)


Franz Cell


Differential Scanning Calorimetry (DSC) / Thermogravimetric Analysis (TGA)

 


Microbiological Analysis


Transepidermal Water Loss (TEWL)


High-Performance Liquid Chromatography (HPLC)


LUMiSizer®


Particle Size Analyzer


Viscosity

Patented technologies proven to solve your challenges.

Salvona's technologies are patented in the USA and worldwide. Our patent wall is probably the first thing you'll notice when you visit our office. All of our technologies solve difficult, real world challenges and have helped our clients develop new, unique products. You'll find our patent numbers on a wide range of products from small independent brands to large, Fortune 500 companies.

Recognized as a leader.

Salvona has received many awards including the Nano 50 award, acknowledging us as a leading company in our field. The New Jersey Center for Biomaterials at Rutgers University named Salvona the Entrepreneurial Company of the Year in 2015.

Salvona was among the winners of Nanotech Briefs' first annual Nano 50™ Awards, which recognize the top 50 technologies, products, and innovators that have significantly impacted – or are expected to impact – the state of the art in nanotechnology.

The winners of the Nano 50 awards are the “best of the best” – the innovative people and designs that will move nanotechnology to key mainstream markets. Nano 50 nominations were judged by a panel of nanotechnology experts. The technologies, products, and innovators receiving the 50 highest scores were named Nano 50 award winners.

Why is Salvona your best source for advanced technologies?

  1. Patented technologies that can be customized and exclusively licensed
  2. Turn-key ability, a logistical ease rather than a challenge
  3. Comprehensive regulatory controls, cGMP FDA facilities
  4. Advanced quality control unlike any other ingredient supplier
  5. Innovative, practical, solutions
  6. Commercial success cases
  7. In-vitro and in-vivo pre-clinical data substantiation
  8. Cost effective production and services